Concepedia

Author

Heike Schönherr

Columbia UniversityORCID

Also Known As

Heike Schonherr, Heike Schönherr

112

Publications

1.6K

Citations

8

H-Index

18

Concepts

All Affiliations

Columbia UniversityD. E. Shaw ResearchRelay Therapeutics (United States)
HS

About

Heike Schönherr is an author at Columbia University specializing in natural sciences, biochemistry, and ophthalmology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Natural Sciences

2

2

49

2

Biochemistry

2

2

49

3

Engineering

1

1

13

4

Medicine

1

1

36

5

Biomolecular Engineering

1

1

13

Heike Schönherr

×

5

Publications

268

Citations

5

H-Index

YearCitations

RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across <i>FGFR2</i> Alterations and Resistance Mutations

Vivek Subbiah, Vaibhav Sahai, Dejan Maglic,

Cancer Discovery

2023

103

Direct and Highly Enantioselective Iso-Pictet–Spengler Reactions with α-Ketoamides: Access to Underexplored Indole Core Structures

Heike Schönherr, James L. Leighton

Organic Letters

2012

63

Discovery of lirafugratinib (RLY-4008), a highly selective irreversible small-molecule inhibitor of FGFR2

Heike Schönherr, Pelin Ayaz, Alexander M. Taylor,

Proceedings of the National Academy of Sciences

2024

53

Synthesis of Antioxidants for Prevention of Age-Related Macular Degeneration

Dharati Joshi, James B. Field, John D. Murphy,

Journal of Natural Products

2013

36

A Chemoenzymatic Approach to the Stereocontrolled Synthesis of the C1–C11 fragment of (+)‐Peloruside A

Heike Schönherr, Jan Mollitor, Christoph Schneider

European Journal of Organic Chemistry

2010

13

Page 1